Endpoints for clinical trials on treatment of hepatitis C.
Kang
Hellan
H
Lok
Anna S F
AS
D000998:Antiviral Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000379:methods*; D016174:Hepacivirus / Q000187:drug effects* / Q000254:growth & development; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans
D000998:Antiviral Agents